[
  {
    "criterion": "Reward for accurately documenting the patient's concern about increased hunger and its potential link to glipizide, including the clinician's explanation of the medication's effect on insulin release.",
    "weight": 20,
    "sense": "positive"
  },
  {
    "criterion": "Reward for noting the patient's observation of lower blood sugar readings since starting glipizide and the clinician's plan to monitor weight and adjust the diet plan if necessary.",
    "weight": 15,
    "sense": "positive"
  },
  {
    "criterion": "Reward for documenting the patient's report of no longer experiencing a cough after switching from lisinopril to losartan, and the clinician's acknowledgment of this improvement.",
    "weight": 10,
    "sense": "positive"
  },
  {
    "criterion": "Reward for including the patient's report of ankle swelling since starting losartan and the clinician's plan to monitor the symptom and consider dose adjustment or alternative options if it persists.",
    "weight": 20,
    "sense": "positive"
  },
  {
    "criterion": "Penalize for omitting any mention of the patient's current medications, specifically glipizide and losartan, in the context of the discussion about their effects and side effects.",
    "weight": 15,
    "sense": "negative"
  },
  {
    "criterion": "Penalize for failing to document a follow-up plan to reassess the patient's weight and ankle swelling, ensuring ongoing monitoring and adjustment of treatment as needed.",
    "weight": 20,
    "sense": "negative"
  }
]